MRNA
BEAR
2026-05-19
Overnight Institutional Flow Signal
Score
6/10
Move
1.6%
Flow
$7.3M
AI Trade Thesis
MRNA BEAR $48.5P May 29 '26. Capitalize on the exhaustion of the recent 20% non-fundamental surge as price action breaks below the $48.40 insider selling level. Target a move toward the primary support at $44.37 as the stock returns to its pre-rally valuation. Risk: Positive clinical trial updates or regulatory news regarding the mCOMBRIAX combination vaccine.
Flow Breakdown
Call Volume
$2.6M
Put Volume
$4.7M
Flow Intent
DIRECTIONAL
Catalyst
Insider Activity
Recommended Setup
ContractO:MRNA260529P00048500
Contract Score10.839/10
Risk/Reward1.4:1
Delta-0.50
Key Levels
Resistance$51.27
Support$43.68
Price$48.11
SMA 50 / 200$51 / $37
52W Range$22 — $60
News & Catalyst Analysis
Key Headline
Moderna President Stephen Hoge Sells 53,336 Shares as Hantavirus-Driven Momentum Exhausts
News Summary
MRNA is experiencing a momentum reversal as the speculative rally triggered by hantavirus headlines fades and analysts dismiss the news as fundamentally non-material. Institutional bearish flow is intensifying following an SEC filing showing the company President sold over $2.5M worth of shares near the $48.40 level, signaling a potential local ceiling.
Flow Intent Analysis
The $4.6M flow appears to be an aggressive bet on a continued pullback following a sentiment-driven spike, rather than a hedge for the minor -1.6% daily move.
One email a week. Catch up in five minutes.
The GammaRips weekly briefing — engine state, the latest deep-dive, and the picks on the public ledger. No firehose, no FOMO.